147 related articles for article (PubMed ID: 28815332)
21. MicroRNA-15a down-regulation is associated with adverse prognosis in human glioma.
Xie T; Liu P; Chen L; Chen Z; Luo Y; Chen X; Feng Y; Luo X
Clin Transl Oncol; 2015 Jul; 17(7):504-10. PubMed ID: 25575767
[TBL] [Abstract][Full Text] [Related]
22. The potential of plasma miRNAs for diagnosis and risk estimation of colorectal cancer.
Chen WY; Zhao XJ; Yu ZF; Hu FL; Liu YP; Cui BB; Dong XS; Zhao YS
Int J Clin Exp Pathol; 2015; 8(6):7092-101. PubMed ID: 26261602
[TBL] [Abstract][Full Text] [Related]
23. High-throughput qRT-PCR validation of blood microRNAs in non-small cell lung cancer.
Leidinger P; Brefort T; Backes C; Krapp M; Galata V; Beier M; Kohlhaas J; Huwer H; Meese E; Keller A
Oncotarget; 2016 Jan; 7(4):4611-23. PubMed ID: 26672767
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
He J; Deng Y; Yang G; Xie W
J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic, grading and prognostic role of a restricted miRNAs signature in primary and metastatic brain tumours. Discussion on their therapeutic perspectives.
Nikolova E; Georgiev C; Laleva L; Milev M; Spiriev T; Stoyanov S; Taseva-Mineva T; Mitev V; Todorova A
Mol Genet Genomics; 2022 Mar; 297(2):357-371. PubMed ID: 35064290
[TBL] [Abstract][Full Text] [Related]
26. Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance.
Shi KQ; Lin Z; Chen XJ; Song M; Wang YQ; Cai YJ; Yang NB; Zheng MH; Dong JZ; Zhang L; Chen YP
Oncotarget; 2015 Sep; 6(28):25093-108. PubMed ID: 26231037
[TBL] [Abstract][Full Text] [Related]
27. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer.
Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G
Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428
[TBL] [Abstract][Full Text] [Related]
28. MiR-338-5p Promotes Glioma Cell Invasion by Regulating TSHZ3 and MMP2.
Li Y; Huang Y; Qi Z; Sun T; Zhou Y
Cell Mol Neurobiol; 2018 Apr; 38(3):669-677. PubMed ID: 28780604
[TBL] [Abstract][Full Text] [Related]
29. Correlation of microRNA-375 downregulation with unfavorable clinical outcome of patients with glioma.
Chang C; Shi H; Wang C; Wang J; Geng N; Jiang X; Wang X
Neurosci Lett; 2012 Dec; 531(2):204-8. PubMed ID: 23103713
[TBL] [Abstract][Full Text] [Related]
30. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
[TBL] [Abstract][Full Text] [Related]
31. Human miR-1228 as a stable endogenous control for the quantification of circulating microRNAs in cancer patients.
Hu J; Wang Z; Liao BY; Yu L; Gao X; Lu S; Wang S; Dai Z; Zhang X; Chen Q; Qiu SJ; Wu Y; Zhu H; Fan J; Zhou J; Wang J
Int J Cancer; 2014 Sep; 135(5):1187-94. PubMed ID: 24488924
[TBL] [Abstract][Full Text] [Related]
32. A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate Cancer.
Daniel R; Wu Q; Williams V; Clark G; Guruli G; Zehner Z
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621736
[TBL] [Abstract][Full Text] [Related]
33. Decreased expression of miR-204 in plasma is associated with a poor prognosis in patients with non-small cell lung cancer.
Guo W; Zhang Y; Zhang Y; Shi Y; Xi J; Fan H; Xu S
Int J Mol Med; 2015 Dec; 36(6):1720-6. PubMed ID: 26497897
[TBL] [Abstract][Full Text] [Related]
34. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
Liu J; Xu J; Li H; Sun C; Yu L; Li Y; Shi C; Zhou X; Bian X; Ping Y; Wen Y; Zhao S; Xu H; Ren L; An T; Wang Q; Yu S
Oncotarget; 2015 Oct; 6(30):29129-42. PubMed ID: 26320176
[TBL] [Abstract][Full Text] [Related]
35. Serum microRNA-210 as a potential noninvasive biomarker for the diagnosis and prognosis of glioma.
Lai NS; Wu DG; Fang XG; Lin YC; Chen SS; Li ZB; Xu SS
Br J Cancer; 2015 Mar; 112(7):1241-6. PubMed ID: 25756397
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of miR-137 and miR-6500-3p promotes cell proliferation in pediatric high-grade gliomas.
Liang ML; Hsieh TH; Ng KH; Tsai YN; Tsai CF; Chao ME; Liu DJ; Chu SS; Chen W; Liu YR; Liu RS; Lin SC; Ho DM; Wong TT; Yang MH; Wang HW
Oncotarget; 2016 Apr; 7(15):19723-37. PubMed ID: 26933822
[TBL] [Abstract][Full Text] [Related]
37. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.
Guan Y; Chen L; Bao Y; Pang C; Cui R; Li G; Liu J; Wang Y
Int J Clin Exp Pathol; 2015; 8(1):727-34. PubMed ID: 25755767
[TBL] [Abstract][Full Text] [Related]
38. Circulating Pre-microRNA-488 in Peripheral Blood Is a Potential Biomarker for Predicting Recurrence in Breast Cancer.
Masuda T; Shinden Y; Noda M; Ueo H; Hu Q; Yoshikawa Y; Tsuruda Y; Kuroda Y; Ito S; Eguchi H; Ohno S; Mimori K
Anticancer Res; 2018 Aug; 38(8):4515-4523. PubMed ID: 30061217
[TBL] [Abstract][Full Text] [Related]
39. Serum microRNA expression signatures as novel noninvasive biomarkers for prediction and prognosis of muscle-invasive bladder cancer.
Jiang X; Du L; Duan W; Wang R; Yan K; Wang L; Li J; Zheng G; Zhang X; Yang Y; Wang C
Oncotarget; 2016 Jun; 7(24):36733-36742. PubMed ID: 27167342
[TBL] [Abstract][Full Text] [Related]
40. Analysis of expression of microRNAs and genes involved in the control of key signaling mechanisms that support or inhibit development of brain tumors of different grades.
Koshkin PA; Chistiakov DA; Nikitin AG; Konovalov AN; Potapov AA; Usachev DY; Pitskhelauri DI; Kobyakov GL; Shishkina LV; Chekhonin VP
Clin Chim Acta; 2014 Mar; 430():55-62. PubMed ID: 24412320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
